Navigation Links
Epilepsy Drug Helps Diabetic Nerve Damage

Over the weekend, researchers from Eastern Virginia Medical School presented their study that shows the anti-epileptic drug topiramate improves diabetic neuropathy, or nerve damage.Topiramate (Topamax) has long been used to treat epilepsy, and recent research shows it can also promote significant weight loss. In a small study of people with type 2 diabetes, the drug showed evidence of improving symptoms and markers of neuropathy.// Neuropathy is damage to the nerves that produces pain, impaired heat and pain perception, and disordered skin blood flow that predisposes a person to skin ulcers. Those ulcers can often be cause for amputation.
Aaron Vinik, M.D., from Eastern Virginia Medical School in Norfolk, presented the results of a study in which he and colleagues gave a daily dose of topiramate (no more than 100 milligrams/day) to 11 participants with neuropathy. At the end of the eight-week study, markers of neuropathy -- dendrite length, intraepidermal nerve fiber density and peroneal nerve amplitude -- all increased in the patients. What that means, explains Dr. Vinik, is that the nerves were healing. Patients also experienced increased sensitivity to touch and a significant reduction in pain.

There are other benefits of the drug for type 2 diabetes patients as well, says Dr. Vinik. His study shows the drug reduced triglycerides, decreased hemoglobin A1C levels (a measure of long-term blood sugar control), lowered LDL or "bad" cholesterol, and lowered total cholesterol. Since about 65 percent of people with diabetes will die of heart disease, these are significant benefits for patients.


'"/>




Page: 1

Related medicine news :

1. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Epilepsy can be predicted
4. Epilepsy Drugs Can Enhance Risk of Birth Defects
5. Epilepsy Drug May Relieve Chronic Headaches
6. More Complications Seen In Women With Epilepsy
7. Epilepsy Drugs Found To Lead To Bone Loss
8. Another Use For Epilepsy Drugs
9. Epilepsy Patients Could Benefit From Pacemakers
10. Early Surgery For Treatment Of Epilepsy Questioned
11. Epilepsy Drug Valproate and Lamotrigine Linked To Malformed Fetus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery ... Arizona pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic ... , Dr. Olson says the decision to support the pageant in an ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based ... however, are unsure how to move forward, given the need to sustain current ... forward tailored to an organization’s specific needs. , PYA Principal Martie Ross states, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: